Original Article

Risk Factors for Failure in Complicated Intraabdominal Infections

Authors: Bryan P. White, PharmD, Jamie L. Wagner, PharmD, Katie E. Barber, PharmD, S. Travis King, PharmD, Kayla R. Stover, PharmD

Abstract

Objectives: Approximately 20% of patients with complicated intraabdominal infections (cIAIs) fail therapy. The purpose of this study was to identify risk factors for clinical failure in patients with cIAIs.

Methods: International Classification of Diseases, Ninth Revision codes for cIAIs were obtained to identify patients. Adult patients who received at least 48 hours of intravenous antibiotics were included. Patients were chronologically matched for age, sex, and comorbidities. The primary outcome was clinical failure. Statistical analysis included bivariate tests and multivariable logistic regression.

Results: A total of 1405 patients were screened; 139 patients were included. The median (interquartile range) age and Charlson Comorbidity Index were 54 (37–62) years and 0 (0–1), respectively. Clinical failure was observed in 47 patients (34%), with 5 deaths (3.6%). Multivariate analysis of the unmatched population showed older age was protective (odds ratio [OR] 0.967, 95% confidence interval [CI] 0.944–0.991). In the matched population elevated serum creatinine (OR 2.2168, 95% CI 1.091–4.308) and increased time to source control (OR 1.015, 95% CI 1.000–1.030) were predictive of clinical failure.

Conclusions: In a low comorbid cIAI population with and without surgical intervention, serum creatinine was an independent risk factor for clinical failure. In the matched case–control of patients, time to source-control procedure was an independent predictor of clinical failure.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133-164.
 
2. Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J Emerg Surg 2014;9:37.
 
3. Krobot K, Yin D, Zhang Q, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004;23:682-687.
 
4. Claridge JA, Banerjee A, Kelly KB, et al. Bacterial species-specific hospital mortality rate for intra-abdominal infections. Surg Infect (Larchmt) 2014;15:194-199.
 
5. Kaffarnik MF, Urban M, Hopt UT, et al. Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care 2012;20:37-48.
 
6. Edelsberg J, Berger A, Schell S, et al. Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) 2008;9:335-347.
 
7. Chong YP, Bae IG, Lee SR, et al. Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections. PLoS One 2015;10:e0119956.
 
8. Inui T, Haridas M, Claridge JA, et al. Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection. Surgery 2009;146:654-662.
 
9. Dietch ZC, Duane TM, Cook CH, et al. Obesity is not associated with antimicrobial treatmentfailure for intra-abdominal infection. Surg Infect (Larchmt) 2016;17:412-421.
 
10. Utzolino S, Ditzel CM, Baier PK, et al. The obesity paradox in surgical intensive care patients with peritonitis. J Crit Care 2014;29:887.e1-5.
 
11. Zakrison TL, Hille DA, Namias N. Effect of body mass index on treatment of complicated intra-abdominal infections in hospitalized adults: comparison of ertapenem with piperacillin-tazobactam. Surg Infect (Larchmt) 2012;13:38-42.
 
12. Sawyer RG, Claridge JA, Nathens AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;372:1996-2005.
 
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
 
14. Dupont WD, Plummer WD, Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19:589-601.
 
15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
 
16. Le Gall JR, Lemeshow S, Saulnier F, et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963.
 
17. Grunau G, Heemken R, Hau T. Predictors of outcome in patients with postoperative intra-abdominal infection. Eur J Surg 1996;162:619-625.
 
18. Mulier S, Penninckx F, Verwaest C, et al. Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 2003;27:379-384.
 
19. Yancik R, Wesley MN, Ries LA, et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer 1998;82:2123-2134.
 
20. Horiuchi A, Watanabe Y, Doi T, et al. Evaluation of prognostic factors and scoring system in colonic perforation. World J Gastroenterol 2007;13:3228-3231.
 
21. Ballian N, Rajamanickam V, Harms BA, et al. Predictors of mortality after emergent surgery for acute colonic diverticulitis: analysis of National Surgical Quality Improvement Project data. J Trauma Acute Care Surg 2013;74:611-616.
 
22. Suarez-de-la-Rica A, Maseda E, Anillo V, et al. Biomarkers (procalcitonin, C reactive protein, and lactate) as predictors of mortality in surgical patients with complicated intra-abdominal infection. Surg Infect (Larchmt) 2015;16:346-351.
 
23. Gauzit R, Pean Y, Barth X, et al. Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: a French prospective observational multicenter study. Surg Infect (Larchmt) 2009;10:119-127.
 
24. van Ruler O, Kiewiet JJ, Boer KR, et al. Failure of available scoring systems to predict ongoing infection in patients with abdominal sepsis after their initial emergency laparotomy. BMC Surg 2011;11:38.
 
25. Bare M, Castells X, Garcia A, et al. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Health Care 2006;22:242-248.
 
26. Sturkenboom M, Goettsch WG, Picelli G, et al. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005;60:438-443.
 
27. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus , enterococcus, gram-negative bacilli, Clostridium difficile , and Candida. Ann Intern Med 2002;136:834-844.
 
28. Hawser SP, Badal RE, Bouchillon SK, et al. Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011. J Infect 2014;68:71-76.
 
29. Solomkin JS, Ramesh MK, Cesnauskas G, et al. Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infections. Antimicrob Agents Chemother 2014;58: 1847-1854.